Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial
Open Access
- 1 April 2006
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 130 (4), 1054-1061
- https://doi.org/10.1053/j.gastro.2006.02.014
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Are there predictors of Remicade treatment success or failure?Advanced Drug Delivery Reviews, 2005
- Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti–tumor necrosis factor therapy in 18,572 patientsArthritis & Rheumatism, 2004
- Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm CountyGut, 2004
- Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's DiseaseNew England Journal of Medicine, 2003
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997
- A controlled double blind study of azathioprine in the management of Crohn's disease.Gut, 1995
- Frequency of glucocorticoid resistance and dependency in Crohn's disease.Gut, 1994
- Clinical, biological, and endoscopic picture of attacks of Crohn's diseaseGastroenterology, 1990
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980